These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32427697)

  • 1. Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma.
    Jeon S; Kwon SY; Ryu YJ; Kang SR; Yoo SW; Cho SG; Kim J; Song HC; Sohn SJ; Bom HS; Min JJ
    Nucl Med Commun; 2020 Aug; 41(8):733-739. PubMed ID: 32427697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
    Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
    Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
    Hei H; Luo Z; Zheng C; Gong W; Zhou B; Fang J; Qin J
    Oral Oncol; 2023 Nov; 146():106563. PubMed ID: 37690364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma.
    Lang BH; Wong KP; Wan KY
    Ann Surg Oncol; 2013 Feb; 20(2):653-9. PubMed ID: 22956067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.
    Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A
    BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preablative Stimulated Thyroglobulin Levels Can Predict Malignant Potential and Therapeutic Responsiveness of Subcentimeter-Sized, 18F-fluorodeoxyglucose-Avid Cervical Lymph Nodes in Patients With Papillary Thyroid Cancer.
    Kwon SY; Kim J; Jung SH; Chong A; Song HC; Bom HS; Min JJ
    Clin Nucl Med; 2016 Jan; 41(1):e32-8. PubMed ID: 26164179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
    Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
    J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of intraoperative neural monitoring during papillary thyroid cancer surgery on completeness of thyroidectomy and thyroglobulin response: a propensity-score matched study.
    Iscan Y; Sengun B; Karatas I; Atalay HB; Sormaz IC; Onder S; Yegen G; Hacisahinogullari H; Tunca F; Giles Senyurek Y
    Acta Chir Belg; 2024 Aug; 124(4):298-306. PubMed ID: 38206297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroglobulin levels and thyroglobulin/thyrotropin ratio could predict the success of the ablative/therapeutic
    Trevizam PG; Tagliarini JV; Castilho EC; de Alencar Marques M; Kiy Y; Mazeto GMFS
    Endocr Res; 2017 Feb; 42(1):42-48. PubMed ID: 27144920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.
    Ma T; Cui J; Shi P; Liang M; Song W; Zhang X; Wang L; Shi Y
    Front Endocrinol (Lausanne); 2023; 14():1158826. PubMed ID: 37790606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Video-Assisted Thyroidectomy for Papillary Thyroid Carcinoma: Oncologic Outcome in Patients with Follow-Up ≥ 10 Years.
    Bellantone R; Raffaelli M; De Crea C; Sessa L; Traini E; Princi P; Lombardi CP
    World J Surg; 2018 Feb; 42(2):402-408. PubMed ID: 29238849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of lymph node yield and lymph node ratio in papillary thyroid carcinoma.
    Vas Nunes JH; Clark JR; Gao K; Chua E; Campbell P; Niles N; Gargya A; Elliott MS
    Thyroid; 2013 Jul; 23(7):811-6. PubMed ID: 23373961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA.
    Deng Y; Zhu G; Ouyang W; Pan L; Feng H; Wu J; Chen P; Wang J; Xian J
    Endocr Pract; 2019 Sep; 25(9):887-898. PubMed ID: 31170371
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.
    Lee CH; Jung JH; Son SH; Hong CM; Jeong JH; Jeong SY; Lee SW; Lee J; Ahn BC
    PLoS One; 2018; 13(8):e0202644. PubMed ID: 30118516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.
    Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
    Ann Surg Treat Res; 2017 Mar; 92(3):117-122. PubMed ID: 28289664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
    Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher adjuvant radioactive iodine therapy dosage helps intermediate-risk papillary thyroid carcinoma patients achieve better therapeutic effect.
    Li X; Zheng H; Ma C; Ji Y; Wang X; Sun D; Meng Z; Zheng W
    Front Endocrinol (Lausanne); 2023; 14():1307325. PubMed ID: 38298190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.